Cancer.Net Specialty Editor: Genitourinary Cancers
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
Dr. Jorge A. Garcia is an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio. A Staff member of the Department of Solid Tumor Oncology and Urology at the Cleveland Clinic Taussig Cancer Institute and Glickman Urological Institute, Dr. Garcia’s work focuses on genitourinary malignancies. He is also the current director of the advanced prostate cancer research program at the Cleveland Clinic.
Dr. Garcia earned his medical degree at the Colombian School of Medicine in Bogota, Colombia (South America). After completing a Cancer Biology Fellowship at Harvard Medical School, Dr. Garcia completed his training in Internal Medicine at the Albert Einstein College of Medicine in New York. Subsequently, Dr. Garcia was awarded a fellowship in hematology and oncology and Urologic Oncology at the University of California San Francisco.
Certified in Medical Oncology and Internal Medicine by the American Board of Internal Medicine, Dr. Garcia’s primary research at the Cleveland Clinic has been in prostate, kidney, and bladder cancer, with special focus on developmental therapeutics and targeted therapy. Dr. Garcia has authored over 100 manuscripts and his research has been published in peer-reviewed journals that include New England Journal of Medicine, Clinical Cancer Research, Journal of Clinical Oncology, Journal of the National Cancer Institute, Lancet Oncology, Journal of Urology, Cancer and BJU International among others. He is also a reviewer for several medical journals including Clinical Cancer Research, Cancer, Urology, Annals of Oncology, Journal of Clinical Oncology, Clinical and Experimental Medicine and the BJU.
Dr. Garcia is a Fellow of the American College of Physicians and serves as a relevance reviewer for the American Board of Internal Medicine. He is also the Chair of the Scientific Protocol Review Committee at the Comprehensive Cancer Center at Case Western Reserve University. Dr. Garcia has also been listed among the best doctors in Cleveland and the United States every year since 2009.
Disclosures: In the past two years, Dr. Garcia has served as a consultant and/or advisor for GlaxoSmithKline, Sanofi, Pfizer, Bayer, Dendreon, and Lpath, and has received honoraria from Astellas Pharma, Pfizer,Bayer, GlaxoSmithKline, and Sanofi. His institution has received research funding from Pfizer, Astellas Pharma, Orion Pharma, Bayer, Janssen Oncology, and Genentech/Roche.
Last Updated: October 2016